albuterol has been researched along with Respiration Disorders in 22 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Perioperative respiratory adverse events (PRAE) remain the leading cause of morbidity and mortality in the paediatric population." | 2.84 | Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children. ( Drake-Brockman, TFE; Hall, GL; Ramgolam, A; Slevin, L; Sommerfield, D; von Ungern-Sternberg, BS; Zhang, G, 2017) |
| "In severe or very severe COPD patients with relatively fixed airway obstruction bronchodilators enhance exercise performance obtained with oxygen." | 2.73 | The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD. ( Calverley, PM; Cortopassi, F; Cukier, A; Ferreira, CA; Ribeiro, M; Stelmach, R, 2007) |
| "Patients with chronic obstructive pulmonary disease (COPD) often report greater relief of breathlessness with nebulised bronchodilators than with the same medicine administered from a metered dose inhaler (MDI)." | 2.71 | Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD. ( Black, PN; Brodie, SM; Poole, PJ; Saini, R, 2005) |
| "We investigated this clinical sign in influenza virus-infected cotton rats (Sigmodon hispidus) and the efficacy of antiviral and anti-inflammatory therapy in reducing symptomatic disease." | 1.32 | Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor. ( Eichelberger, MC; Ottolini, MG; Prince, GA, 2004) |
| " We conclude that sputum induction using a relatively low output ultrasonic nebulizer with premedication with salbutamol is successful and safe in the majority of patients with asthma and other airway conditions." | 1.30 | The safety and success rate of sputum induction using a low output ultrasonic nebuliser. ( Hunter, CJ; Pavord, ID; Ward, R; Wardlaw, AJ; Woltmann, G, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (18.18) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ramgolam, A | 1 |
| Hall, GL | 2 |
| Sommerfield, D | 1 |
| Slevin, L | 1 |
| Drake-Brockman, TFE | 1 |
| Zhang, G | 1 |
| von Ungern-Sternberg, BS | 1 |
| Vengerovich, NG | 1 |
| Drachkova, IM | 1 |
| Yudin, MA | 1 |
| Bykov, VN | 1 |
| Sarana, AM | 1 |
| Bissell, K | 1 |
| Perrin, C | 1 |
| Beran, D | 1 |
| Macleod, KA | 1 |
| Horsley, AR | 1 |
| Bell, NJ | 1 |
| Greening, AP | 1 |
| Innes, JA | 1 |
| Cunningham, S | 1 |
| Koumbourlis, AC | 1 |
| Mroueh, S | 1 |
| Armangil, D | 1 |
| Yurdakök, M | 1 |
| Korkmaz, A | 1 |
| Yiğit, S | 1 |
| Tekinalp, G | 1 |
| Jenkins, C | 1 |
| Seccombe, L | 1 |
| Tomlins, R | 1 |
| Hailemariam, Y | 1 |
| Amiri, HM | 1 |
| Nugent, K | 1 |
| Miller, DD | 1 |
| Amin, MM | 1 |
| Palmer, LB | 1 |
| Shah, AR | 1 |
| Smaldone, GC | 1 |
| Eichelberger, MC | 1 |
| Prince, GA | 1 |
| Ottolini, MG | 1 |
| Mishuk, VP | 1 |
| Mishuk, OA | 1 |
| Hazir, T | 1 |
| Qazi, S | 1 |
| Bin Nisar, Y | 1 |
| Ansari, S | 1 |
| Maqbool, S | 1 |
| Randhawa, S | 1 |
| Kundi, Z | 1 |
| Asghar, R | 1 |
| Aslam, S | 1 |
| Poole, PJ | 1 |
| Saini, R | 1 |
| Brodie, SM | 1 |
| Black, PN | 1 |
| Cukier, A | 1 |
| Ferreira, CA | 1 |
| Stelmach, R | 1 |
| Ribeiro, M | 1 |
| Cortopassi, F | 1 |
| Calverley, PM | 1 |
| Lehmann, S | 1 |
| Bakke, PS | 1 |
| Eide, GE | 1 |
| Gulsvik, A | 1 |
| Thamrin, C | 1 |
| Gangell, CL | 1 |
| Udomittipong, K | 1 |
| Kusel, MM | 1 |
| Patterson, H | 1 |
| Fukushima, T | 1 |
| Schultz, A | 1 |
| Stick, SM | 1 |
| Sly, PD | 1 |
| Chapman, KR | 1 |
| Soler, M | 1 |
| Raszynski, A | 1 |
| Kandrotas, RJ | 1 |
| Sussmane, JB | 1 |
| Aznavorian, R | 1 |
| Wolfsdorf, J | 1 |
| Hunter, CJ | 1 |
| Ward, R | 1 |
| Woltmann, G | 1 |
| Wardlaw, AJ | 1 |
| Pavord, ID | 1 |
| Garner, SS | 1 |
| Wiest, DB | 1 |
| Bradley, JW | 1 |
| Habib, DM | 1 |
| Handelsman, E | 1 |
| Voulalas, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Changes in the Lung Clearance Index as Measured by Multiple-breath Washout, in Pediatric Patients With Asthma After Challenge With Inhaled Steroids and Short-acting Bronchodilator[NCT02678949] | 105 participants (Anticipated) | Interventional | 2016-03-31 | Not yet recruiting | |||
| The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Ventrucular Septal Defect Patients With Persistant or Surgically Corrected Conditions - The VENTI Trial[NCT02914652] | Phase 4 | 96 participants (Actual) | Interventional | 2016-10-15 | Completed | ||
| Adiposity and Airway Inflammation in HIV-Associated Airway Disease[NCT02975258] | 102 participants (Actual) | Observational | 2015-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for albuterol and Respiration Disorders
| Article | Year |
|---|---|
Acute respiratory symptoms following massive carbon black exposure.
Topics: Accidents, Occupational; Adult; Albuterol; Androstadienes; Bronchodilator Agents; Fluticasone; Force | 2012 |
8 trials available for albuterol and Respiration Disorders
| Article | Year |
|---|---|
Premedication with salbutamol prior to surgery does not decrease the risk of perioperative respiratory adverse events in school-aged children.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Albuterol; Child; Double-Blind Method; Female; Huma | 2017 |
Ventilation heterogeneity in children with well controlled asthma with normal spirometry indicates residual airways disease.
Topics: Adolescent; Albuterol; Asthma; Bronchial Diseases; Bronchodilator Agents; Case-Control Studies; Chil | 2009 |
Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn.
Topics: Adrenergic beta-2 Receptor Agonists; Albuterol; Carbon Dioxide; Double-Blind Method; Female; Humans; | 2011 |
Comparison of clinical outcome with oral and inhaled bronchodilators in the management of wheezy children aged 1-59 months in the community: a randomised trial in Pakistan.
Topics: Administration, Inhalation; Administration, Oral; Albuterol; Bronchodilator Agents; Child; Child, Pr | 2004 |
Comparison of the effects of nebulised and inhaled salbutamol on breathlessness in severe COPD.
Topics: Aged; Aged, 80 and over; Albuterol; Anesthetics, Local; Bronchodilator Agents; Cross-Over Studies; F | 2005 |
The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD.
Topics: Aged; Albuterol; Bronchodilator Agents; Combined Modality Therapy; Cross-Over Studies; Dyspnea; Exer | 2007 |
Fewer interventions in the immediate post-extubation management of pediatric intensive care unit patients: safety and cost containment.
Topics: Administration, Inhalation; Adolescent; Albuterol; Blood Pressure; Bronchodilator Agents; Child; Chi | 1997 |
Two administration methods for inhaled salbutamol in intubated patients.
Topics: Albuterol; Blood Pressure; Bronchodilator Agents; Catheterization, Peripheral; Child; Child, Prescho | 2002 |
13 other studies available for albuterol and Respiration Disorders
| Article | Year |
|---|---|
Experimental Substantiation of Inhalation Administration of Pathogenic Therapy of Toxic Convulsive Disorder for Correction of External Respiration Disorders.
Topics: Administration, Inhalation; Albuterol; Animals; Atropine; Bronchodilator Agents; Convulsants; Diazep | 2018 |
Access to essential medicines to treat chronic respiratory disease in low-income countries.
Topics: Albuterol; Anti-Asthmatic Agents; Beclomethasone; Burkina Faso; Chronic Disease; Developing Countrie | 2016 |
Oral corticosteroids in children with wheezing.
Topics: Administration, Oral; Albuterol; Bronchodilator Agents; Child, Preschool; Glucocorticoids; Humans; P | 2009 |
Oral corticosteroids in children with wheezing.
Topics: Administration, Oral; Albuterol; Bronchodilator Agents; Child, Preschool; Glucocorticoids; Humans; P | 2009 |
Investigating asthma symptoms in primary care.
Topics: Adult; Albuterol; Asthma; Bronchial Provocation Tests; Bronchodilator Agents; Child; Diagnosis, Diff | 2012 |
Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation.
Topics: Administration, Inhalation; Aerosols; Albuterol; Anti-Bacterial Agents; Bronchodilator Agents; Human | 2003 |
Influenza-induced tachypnea is prevented in immune cotton rats, but cannot be treated with an anti-inflammatory steroid or a neuraminidase inhibitor.
Topics: Albuterol; Animals; Anti-Inflammatory Agents; Antiviral Agents; Bronchodilator Agents; Disease Model | 2004 |
[Diurnal variations of the respiratory system in patients with pulmonary tuberculosis].
Topics: Adolescent; Adult; Albuterol; Bronchial Spasm; Bronchodilator Agents; Circadian Rhythm; Female; Huma | 2004 |
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Albuterol; Body Mass Index; Bronchoconstriction; Bronch | 2007 |
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Albuterol; Body Mass Index; Bronchoconstriction; Bronch | 2007 |
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Albuterol; Body Mass Index; Bronchoconstriction; Bronch | 2007 |
Bronchodilator response to adrenergic beta2-agonists: relationship to symptoms in an adult community.
Topics: Adrenergic beta-Agonists; Age Factors; Aged; Albuterol; Body Mass Index; Bronchoconstriction; Bronch | 2007 |
Assessment of bronchodilator responsiveness in preschool children using forced oscillations.
Topics: Albuterol; Bronchi; Bronchodilator Agents; Child; Child, Preschool; Female; Humans; Male; Respiratio | 2007 |
Aerosol therapy in Canada: what are the standards?
Topics: Aerosols; Albuterol; Equipment Design; Humans; Nebulizers and Vaporizers; Research Design; Respirati | 1993 |
The safety and success rate of sputum induction using a low output ultrasonic nebuliser.
Topics: Adolescent; Adult; Aged; Albuterol; Bronchodilator Agents; Cell Count; Female; Forced Expiratory Vol | 1999 |
Albuterol inhalations in acute chest syndrome.
Topics: Acute Disease; Aerosols; Albuterol; Anemia, Sickle Cell; Child; Humans; Lung Diseases; Male; Respira | 1991 |